ResearchSevere autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1
ResearchEvaluating datopotamab deruxtecan (Dato-DXd) as a novel treatment option for EGFR-mutated non-small cell lung cancer
ResearchStereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer
ResearchCharacteristics of clinical trials associated with appeal and return on investment to participants: a review and framework
ResearchDifferences in Clinical Trial Availability vs Distribution of Disease Among Gynecological Cancers
ResearchExpanding Lung Cancer Clinical Trial Criteria: A Systematic Review on Inclusion of Patients with Brain Metastases and Leptomeningeal Disease
ResearchA phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol
ResearchImmune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC